TIOSPIREX 13 mcg inhalation powder hard capsule Singapur - inglés - HSA (Health Sciences Authority)

tiospirex 13 mcg inhalation powder hard capsule

dksh singapore pte. ltd. - tiotropium bromide 0.0156 mg eqv tiotropium - capsule - tiotropium bromide 0.0156 mg eqv tiotropium 0.013mg

SPIRIVA INHALATION CAPSULE 18 mcg with HandiHaler Singapur - inglés - HSA (Health Sciences Authority)

spiriva inhalation capsule 18 mcg with handihaler

boehringer ingelheim singapore pte. ltd. - tiotropium bromide monohydrate eqv tiotropium - capsule - 18 mcg

SPIRIVA Inhalation Powder, Capsule 18 Microgram Irlanda - inglés - HPRA (Health Products Regulatory Authority)

spiriva inhalation powder, capsule 18 microgram

profind wholesale ltd. - tiotropium tiotropium bromide - inhalation powder, capsule - 18 microgram

SPIRIVA Inhalation Powder, Capsule 18 Microgram Irlanda - inglés - HPRA (Health Products Regulatory Authority)

spiriva inhalation powder, capsule 18 microgram

ips healthcare limited - tiotropium tiotropium bromide - inhalation powder, capsule - 18 microgram

SPIRIVA Australia - inglés - Department of Health (Therapeutic Goods Administration)

spiriva

boehringer ingelheim pty ltd - tiotropium -

Spiriva Capsules Namibia - inglés - Namibia Medicines Regulatory Council

spiriva capsules

bohringer ingelheim - tiotropiumbromide monohydrate - capsules - each capsule contains tiotropiumbromide monohydrate 22.?g corresponding to tiotropium 18?g

Spiolto Respimat 2.5 µg/dose - 2.5 µg/dose inhal. sol. cartr. Bélgica - inglés - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

spiolto respimat 2.5 µg/dose - 2.5 µg/dose inhal. sol. cartr.

boehringer ingelheim international gmbh - tiotropium bromide monohydrate 3,1 µg/dose - eq. tiotropium 2,5 µg/dose; olodaterol hydrochloride 2,7 µg/dose - eq. olodaterol 2,5 µg/dose - inhalation solution - 2,5 µg/dose - 2,5 µg/dose - tiotropium bromide monohydrate 3.1 µg/dose; olodaterol hydrochloride 2.7 µg/dose - olodaterol and tiotropiumbromide

Yanimo Respimat 2.5 µg/dose - 2.5 µg/dose inhal. sol. cartr. Bélgica - inglés - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

yanimo respimat 2.5 µg/dose - 2.5 µg/dose inhal. sol. cartr.

boehringer ingelheim international gmbh - tiotropium bromide monohydrate 3,1 µg/dose - eq. tiotropium 2,5 µg/dose; olodaterol hydrochloride 2,7 µg/dose - eq. olodaterol 2,5 µg/dose - inhalation solution - 2,5 µg/dose - 2,5 µg/dose - tiotropium bromide monohydrate 3.1 µg/dose; olodaterol hydrochloride 2.7 µg/dose - olodaterol and tiotropiumbromide

YANIMO RESPIMAT 2.5 micrograms/2.5 micrograms tiotropium (as bromide monohydrate)/olodaterol (as hydrochloride) solution for inh Australia - inglés - Department of Health (Therapeutic Goods Administration)

yanimo respimat 2.5 micrograms/2.5 micrograms tiotropium (as bromide monohydrate)/olodaterol (as hydrochloride) solution for inh

boehringer ingelheim pty ltd - olodaterol hydrochloride, quantity: 2.736 microgram/actuation (equivalent: olodaterol, qty 2.5 microgram/actuation); tiotropium bromide monohydrate, quantity: 3.124 microgram/actuation (equivalent: tiotropium, qty 2.5 microgram/actuation) - inhalation, conventional - excipient ingredients: purified water; benzalkonium chloride; hydrochloric acid; disodium edetate - yanimo respimat is indicated as a once-daily maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).

Braltus Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

braltus

teva pharma (new zealand) limited - tiotropium bromide monomethanolate 16.71ug equivalent to 15.6 µg tiotropium bromide and 13 µg tiotropium (delivered dose: 10 µg tiotropium);   - powder filled inhalation capsule - 13 mcg - active: tiotropium bromide monomethanolate 16.71ug equivalent to 15.6 µg tiotropium bromide and 13 µg tiotropium (delivered dose: 10 µg tiotropium)   excipient: cap hpmc - 536105 lactose monohydrate - braltus is indicated for the long term once daily maintenance treatment of bronchospasm and dyspnoea associated with chronic obstructive pulmonary disease (copd), including chronic bronchitis and emphysema. braltus reduces the frequency of exacerbations and improves exercise tolerance and health-related quality of life.